Want to see VSEE full AI Analyst Report?
VSEE Stock Chart & Stats
$0.02
>-$0.01(-1.27%)
At close: 4:00 PM EDT
$0.02
>-$0.01(-1.27%)
Day’s Range― - ―
52-Week Range<$0.01 - $2.52
Previous Close$0.08
Volume3.12M
Average Volume (3M)14.24M
Market Cap
$850.20K
Enterprise Value$7.77
Total Cash (Recent Filing)$454.15K
Total Debt (Recent Filing)$1.88M
Price to Earnings (P/E)―
Beta0.51
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding56,679,813
10 Day Avg. Volume932,653
30 Day Avg. Volume14,238,639
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.38
Price to Sales (P/S)0.52
P/FCF Ratio-2.17
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Recurring Telehealth And RPM Software ModelSubscription software, enterprise contracts, and RPM programs can create recurring revenue and deepen workflow integration with providers. HIPAA compliance and connected-device capabilities may support customer retention and expansion as virtual care becomes embedded in healthcare delivery.
Moderate Reported LeverageReported leverage remains moderate, giving the company more balance-sheet flexibility than a highly indebted peer despite operating losses. This is a relative strength for funding operations, although historical negative equity and ongoing losses reduce the durability of that cushion.
VSee Lab Divestiture And Leadership ConsolidationThe divestiture narrows the corporate structure and removes VSee Lab's post-closing liabilities, potentially improving focus on the core platform. Consolidating leadership under the remaining co-CEO may also simplify accountability during the company's restructuring.
Bears Say
Declining Revenue And Persistent LossesRevenue contraction indicates weakening scale in the core business, while a cost base far above revenue prevents operating leverage. Without sustained growth or restructuring, persistent losses could limit investment, weaken competitiveness, and prolong dependence on external capital.
Persistent Operating Cash BurnThe business is not currently self-funding, making liquidity dependent on financing or operational improvement. Continued cash consumption can force expensive borrowing or equity issuance, reducing financial flexibility and increasing the risk that strategic initiatives cannot be sustained.
Financing, Dilution, And Listing RiskDelisting can reduce access to institutional capital and visibility, while discounted convertibles and lender claims can divert future cash and dilute existing holders. Together, these pressures signal constrained financing options and may complicate the company's ability to fund growth.
VSee Health News
VSEE FAQ
What was VSee Health’s price range in the past 12 months?
VSee Health lowest stock price was <$0.01 and its highest was $2.52 in the past 12 months.
What is VSee Health’s market cap?
VSee Health’s market cap is $850.20K.
When is VSee Health’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were VSee Health’s earnings last quarter?
Currently, no data Available
Is VSee Health overvalued?
According to Wall Street analysts VSee Health’s price is currently Overvalued.
Does VSee Health pay dividends?
VSee Health does not currently pay dividends.
What is VSee Health’s EPS estimate?
VSee Health’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does VSee Health have?
VSee Health has 56,679,813 shares outstanding.
What happened to VSee Health’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of VSee Health?
Currently, no hedge funds are holding shares in VSEE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
VSee Health
VSee Health, Inc. specializes in delivering virtual healthcare solutions. Their flagship offering, iDoc Telehealth, is specifically designed to manage and coordinate comprehensive care for severely ill individuals within various critical care environments, including neurointensive, cardiac intensive, and general intensive care units (ICUs). This system addresses complex conditions such as stroke, spinal cord injuries, brain trauma, and other severe neurological disorders. Beyond specialized care, their broader telehealth platform provides a modular suite of digital tools, empowering clients to customize solutions to their unique needs. VSee Health, Inc. is headquartered in Newton, Massachusetts.
Technical Analysis
Ownership Overview
9.72% Insiders
0.49% Mutual Funds
7.22% Other Institutional Investors
82.19% Public Companies and
Individual Investors